Intermittent bolus infusion of methylene blue [methylthioninium chloride] to reduce norepinephrine requirements in sepsis: a randomized controlled trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Methylthioninium chloride (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- Acronyms SMURF
- 29 May 2008 Biomarkers information updated
- 06 Aug 2007 New trial record.